Publications

American Association of Cancer Research (AACR) ComPACT preclinical poster, May 29, 2019

2019 ASCO-SITC Clinical Immuno-Oncology Symposium Poster

Nature Biopharma, “Harnessing the Immune System to Turn Cold Tumors Hot”

Nature Biopharma, “Activating Antitumor Activity”

Gp96-Ig/costimulator (OX40L, ICOSL, or 4-1BBL) Combination Vaccine Improves T cell Priming and Enhances Immunity, Memory, and Tumor Elimination Heat Biologics 2017

Viagenpumatucel-L (HS-110) with Nivolumab in the Ongoing DURGA Trial Heat Biologics 2016

Viagenpumatucel-L (HS-110) Bolsters Response to Nivolumab Therapy in Advanced Lung Adenocarcinoma: Preliminary Data From The DURGA Trial Heat Biologics 2016

In vivo Intratumoral Electroporation of Gp96-Ig/Fc-OX40L Stimulates CD8+ T cell Cross Priming to Tumor-Specific Neoantigens Heat Biologics 2016

Combination Immunotherapy: T-cell costimulation (OX40L, ICOSL, and 4-1BBL) secreted locally by Gp96-Ig vaccines, elicits robust antigenspecific, memory T cell responses and tumor elimination Heat Biologics 2016

Gp96-Ig/costimulator (OX40L, ICOSL, or 4-1BBL) Combination Vaccine Improves T cell Priming and Enhances Immunity, Memory, and Tumor Elimination Heat Biologics 2016